Wang, L. et al. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front. Public. Health 10, 811044 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17–48 (2023).

Article  PubMed  Google Scholar 

Giaquinto, A. N. et al. Cancer statistics for African American/Black People 2022. CA Cancer J. Clin. https://doi.org/10.3322/caac.21718 (2022).

Article  PubMed  Google Scholar 

Chowdhury-Paulino, I. M. et al. Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer Prostatic Dis. 25, 397–402 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Conti, D. V. et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat. Genet. 53, 65–75 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moses, K. A., Orom, H., Brasel, A., Gaddy, J. & Underwood, W. III Racial/ethnic disparity in treatment for prostate cancer: does cancer severity matter? Urology 99, 76–83 (2017).

Article  PubMed  Google Scholar 

Schwartz, K. et al. Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer. Urology 74, 1296–1302 (2009).

Article  PubMed  Google Scholar 

Odedina, F. T. et al. Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa. Infect. Agent. Cancer 4, S2 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Powell, I. J., Bock, C. H., Ruterbusch, J. J. & Sakr, W. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J. Urol. 183, 1792–1796 (2010).

Article  PubMed  Google Scholar 

Thompson, I. et al. Association of African-American ethnic background with survival in men with metastatic prostate cancer. J. Natl Cancer Inst. 93, 219–225 (2001).

Article  CAS  PubMed  Google Scholar 

Hoffman, R. M. et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J. Natl Cancer Inst. 93, 388–395 (2001).

Article  CAS  PubMed  Google Scholar 

Du, X. L. et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 106, 1276–1285 (2006).

Article  PubMed  Google Scholar 

Moul, J. W. et al. Prostate-specific antigen values at the time of prostate cancer diagnosis African-American men. JAMA 274, 1277–1281 (1995).

Article  CAS  PubMed  Google Scholar 

Tiguert, R. et al. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens. Prostate 37, 230–235 (1998).

Article  CAS  PubMed  Google Scholar 

Sundi, D. et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J. Urol. 191, 60–67 (2014).

Article  PubMed  Google Scholar 

Tsodikov, A. et al. Is prostate cancer different in black men? Answers from 3 natural history models. Cancer 123, 2312–2319 (2017).

Article  PubMed  Google Scholar 

Darst, B. F. et al. A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry. Eur. Urol. 81, 458–462 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Darst, B. F. et al. A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry. Eur. Urol. 78, 316–320 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okobia, M. N., Zmuda, J. M., Ferrell, R. E., Patrick, A. L. & Bunker, C. H. Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry. Prostate 71, 1054–1063 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bock, C. H. et al. Results from a prostate cancer admixture mapping study in African-American men. Hum. Genet. 126, 637–642 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han, D. et al. Susceptibility-associated genetic variation in NEDD9 contributes to prostate cancer initiation and progression. Cancer Res. 81, 3766–3776 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conti, D. V. et al. Two novel susceptibility loci for prostate cancer in men of African ancestry. J. Natl Cancer Inst. 109, djx084 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Bonilla, C., Hooker, S., Mason, T., Bock, C. H. & Kittles, R. A. Prostate cancer susceptibility loci identified on chromosome 12 in African Americans. PLoS ONE 6, e16044 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ricks-Santi, L. et al. p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate 70, 1739–1745 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taioli, E. et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis 32, 1361–1365 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han, Y. et al. Prostate cancer susceptibility in men of African ancestry at 8q24. J. Natl Cancer Inst. 108, djv431 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Barnabas, N., Xu, L., Savera, A., Hou, Z. & Barrack, E. R. Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene. Prostate 71, 857–871 (2011).

Article  CAS  PubMed  Google Scholar 

Robbins, C. et al. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res. 17, 1717–1722 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amundadottir, L. T. et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38, 652–658 (2006).

Article  CAS  PubMed  Google Scholar 

Freedman, M. L. et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl Acad. Sci. USA 103, 14068–14073 (2006).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haiman, C. A. et al. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet. 7, e1001387 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haiman, C. A. et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet. 39, 638–644 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han, Y. et al. Generalizability of established prostate cancer risk variants in men of African ancestry. Int. J. Cancer 136, 1210–1217 (2015).

Article  CAS  PubMed  Google Scholar 

Walavalkar, K. et al. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer. Nat. Commun. 11, 3598 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giorgi, E. E. et al. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study. Cancer Epidemiol. Biomark. Prev. 23, 1928–1932 (2014).

Article  CAS  Google Scholar 

Clark, A. S., West, K., Streicher, S. & Dennis, P. A. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 1, 707–717 (2002).

CAS  PubMed  Google Scholar 

Faridi, J., Wang, L., Endemann, G. & Roth, R. A. Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo. Clin. Cancer Res. 9, 2933–2939 (2003).

CAS